Just 3-4 prunes daily can make a significant difference
Patients who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their clinician before use
Ozempic has emerged as a significant player in helping individuals manage their weight related medical conditions through its effects on appetite and its role as a GLP-1 receptor agonist
"Brands can better serve these consumers by focusing on solutions that enhance skin elasticity and firmness," Lindsay Cameron, a health and wellness analyst at Mintel, told Glossy
Zepbound is a combined glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol, or cardiovascular disease and is to be used in addition to a reduced calorie diet and increased physical activity
Adding to the discussion, a 2025 study from the University of Michigan, presented at the Endocrine Societys annual meeting, found that obese mice treated with tirzepatide lost about 20% of their body weight and developed significantly smaller breast tumors than control mice